Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Center, Open, Single Arm Phase II Clinical Study of Fruquintinib in the Treatment of Soft Tissue Sarcoma

NCT05142631 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT05142631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05142631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Center, Open, Single Arm Phase II Clinical Study of Fruquintinib in the Treatment of Soft Tissue Sarcoma
Lead sponsor
Fudan University
Phase
Phase 2
Overall status
Unknown status
Start date
November 21, 2021
Completion date
August 30, 2023
Enrollment
31 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

soft tissue sarcoma